Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleBEHAVIORAL PHARMACOLOGY

Human Urocortin 2, a Corticotropin-Releasing Factor (CRF)2 Agonist, and Ovine CRF, a CRF1 Agonist, Differentially Alter Feeding and Motor Activity

Eric P. Zorrilla, Lindsay E. Reinhardt, Glenn R. Valdez, Koki Inoue, Jean E. Rivier, Wylie W. Vale and George F. Koob
Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1027-1034; DOI: https://doi.org/10.1124/jpet.104.068676
Eric P. Zorrilla
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lindsay E. Reinhardt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Glenn R. Valdez
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Koki Inoue
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean E. Rivier
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wylie W. Vale
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George F. Koob
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 310 no. 3 1027-1034
DOI 
https://doi.org/10.1124/jpet.104.068676
PubMed 
15115804

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Received March 18, 2004
  • Accepted April 28, 2004
  • Published online August 20, 2004.

Article Versions

  • Earlier version (April 28, 2004 - 12:41).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Eric P. Zorrilla,
  2. Lindsay E. Reinhardt,
  3. Glenn R. Valdez,
  4. Koki Inoue,
  5. Jean E. Rivier,
  6. Wylie W. Vale and
  7. George F. Koob
  1. Department of Neuropharmacology, The Scripps Research Institute, La Jolla, California (E.P.Z., L.E.R., G.R.V., K.I., G.F.K.); Department of Neuropsychiatry, Osaka City University Medical School, Osaka, Japan (K.I.); and Peptide Biology Laboratory, The Salk Institute for Biological Sciences, La Jolla, California (J.E.R., W.W.V.)
  1. Address correspondence to:
    Dr. Eric P. Zorrilla, Department of Neuropharmacology, CVN-7, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037. E-mail: ezorrilla{at}scripps.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: May 2004 to March 2023

AbstractFullPdf
Apr 200417020
May 200450092
Jun 200465033
Jul 200473031
Aug 20041393473
Sep 2004925651
Oct 2004744237
Nov 2004583232
Dec 2004423814
Jan 2005525518
Feb 2005262515
Mar 2005243716
Apr 200562211
May 2005112710
Jun 20057346
Jul 200517213
Aug 20059238
Sep 200531610
Oct 200572522
Nov 200542310
Dec 200572210
Jan 20067159
Feb 200672120
Mar 200623615
Apr 200651611
May 20062237
Jun 2006131111
Jul 200631611
Aug 20063154
Sep 200621112
Oct 2006112315
Nov 200651514
Dec 20065178
Jan 200751512
Feb 200741110
Mar 20072127
Apr 200751811
May 200761715
Jun 20076810
Jul 20074611
Aug 200781614
Sep 2007635
Oct 2007101718
Nov 200710616
Dec 20077125
Jan 2008786
Feb 200871410
Mar 20084157
Apr 2008112215
May 200881022
Jun 2008152811
Jul 200881623
Aug 2008457
Sep 20081568
Oct 20081383
Nov 2008111311
Dec 2008857
Jan 200981216
Feb 2009759
Mar 2009241312
Apr 200912108
May 2009974
Jun 20091278
Jul 2009155
Aug 20091694
Sep 20091459
Oct 20091863
Nov 2009561
Dec 20091545
Jan 20102133
Feb 20101173
Mar 20101246
Apr 20102095
May 20101475
Jun 2010887
Jul 20106910
Aug 201014811
Sep 20109139
Oct 2010758
Nov 20105119
Dec 2010763
Jan 2011688
Feb 2011845
Mar 201114710
Apr 201114818
May 20118722
Jun 20111068
Jul 20117211
Aug 201115716
Sep 20111166
Oct 2011331617
Nov 2011212016
Dec 20116810
Jan 201224812
Feb 20128118
Mar 20121699
Apr 201211107
May 20128410
Jun 201210107
Jul 201291811
Aug 20121088
Sep 2012957
Oct 201211119
Nov 20121077
Dec 20125149
Jan 20139216
Feb 20139149
Mar 2013899
Apr 2013141321
May 201371122
Jun 20138817
Jul 201381016
Aug 2013944
Sep 201382012
Oct 201315297
Nov 2013788
Dec 20135126
Jan 20147816
Feb 20147913
Mar 2014102211
Apr 201416923
May 201410729
Jun 20145419
Jul 201421118
Aug 2014510
Sep 201461375
Oct 201421864
Nov 2014171694
Dec 2014141546
Jan 201514663
Feb 20151571
Mar 20155688
Apr 201544510
May 20158584
Jun 20154403
Jul 201553713
Aug 20157374
Sep 20157375
Oct 20154352
Nov 20154320
Dec 201513367
Jan 201673510
Feb 201616358
Mar 201613394
Apr 201613375
May 20169505
Jun 201634614
Jul 201658014
Aug 2016146921
Sep 20162429
Oct 20162605
Nov 20162310
Dec 20162413
Jan 20170560
Feb 20171674
Mar 20171743
Apr 20170664
May 20170733
Jun 20171696
Jul 20172703
Aug 201707610
Sep 20172722
Oct 20170787
Nov 20170786
Dec 20170851
Jan 20180780
Feb 20180766
Mar 20182794
Apr 201818816
May 201805112
Jun 201807810
Jul 201804410
Aug 20181476
Sep 20180445
Oct 20180451
Nov 20181427
Dec 201814311
Jan 201911314
Feb 20195203
Mar 20191114
Apr 20191507
May 20191508
Jun 20191533
Jul 20191901
Aug 20191604
Sep 20193203
Oct 20191203
Nov 20192827
Dec 20192602
Jan 2020912
Feb 20201310
Mar 2020200
Apr 20201000
May 2020701
Jun 2020300
Jul 2020801
Aug 2020901
Sep 2020934
Oct 2020802
Nov 20201005
Dec 20201901
Jan 20211412
Feb 20211013
Mar 20211712
Apr 20211011
May 20212447
Jun 2021522
Jul 20211312
Aug 20212121
Sep 2021814
Oct 20211135
Nov 2021925
Dec 20211802
Jan 20221757
Feb 2022511
Mar 2022237
Apr 20221315
May 2022510
Jun 2022620
Jul 20221221
Aug 20221825
Sep 20222215
Oct 2022910
Nov 20221811
Dec 2022511
Jan 20232263
Feb 2023710
Mar 20231635

PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 310 (3)
Journal of Pharmacology and Experimental Therapeutics
Vol. 310, Issue 3
1 Sep 2004
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Human Urocortin 2, a Corticotropin-Releasing Factor (CRF)2 Agonist, and Ovine CRF, a CRF1 Agonist, Differentially Alter Feeding and Motor Activity
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleBEHAVIORAL PHARMACOLOGY

Human Urocortin 2, a Corticotropin-Releasing Factor (CRF)2 Agonist, and Ovine CRF, a CRF1 Agonist, Differentially Alter Feeding and Motor Activity

Eric P. Zorrilla, Lindsay E. Reinhardt, Glenn R. Valdez, Koki Inoue, Jean E. Rivier, Wylie W. Vale and George F. Koob
Journal of Pharmacology and Experimental Therapeutics September 1, 2004, 310 (3) 1027-1034; DOI: https://doi.org/10.1124/jpet.104.068676

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleBEHAVIORAL PHARMACOLOGY

Human Urocortin 2, a Corticotropin-Releasing Factor (CRF)2 Agonist, and Ovine CRF, a CRF1 Agonist, Differentially Alter Feeding and Motor Activity

Eric P. Zorrilla, Lindsay E. Reinhardt, Glenn R. Valdez, Koki Inoue, Jean E. Rivier, Wylie W. Vale and George F. Koob
Journal of Pharmacology and Experimental Therapeutics September 1, 2004, 310 (3) 1027-1034; DOI: https://doi.org/10.1124/jpet.104.068676
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Cromakalim prodrugs are analgesics in chronic pain models
  • Role of Residues S426 and S430 in Cannabinoid Tolerance
  • Running Title: Stimulus effects of nicotine aerosol
Show more Behavioral Pharmacology

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics